Novartis AG (NYSE:NVS) released new data Wednesday from the ALITHIOS open-label extension study. Data show first-line ...

HOUSTON — Bruton's tyrosine kinase inhibitors such as ibrutinib, acalabrutinib, and zanubrutinib have revolutionized the ...

The decision to discontinue BTK inhibitor treatment for CLL is complex, with emerging data suggesting that time-limited ...

One rival to Imjudo/Imfinzi in previously untreated HCC is Roche's dual regimen of PD-L1 inhibitor Tecentriq (atezolizumab) and CD20-targeting antibody Avastin (bevacizumab), which was approved by ...

CD20 is found on the surface of all normal B ... Such combinations include an immunomodulatory agent (lenalidomide), a checkpoint inhibitor (atezolizumab), a Bcl2 inhibitor (venetoclax) or an ...

We came across a bullish thesis on TG Therapeutics Inc (TGTX) on ValueInvestorsClub by Bohr. In this article we will ...

Susac syndrome is a rare inflammatory vascular endotheliopathy affecting the small vessels of the brain, eye, and ear.1,2 ...

In addition, some antibodies bind to different epitopes of CD20, which may yield different ... are also of interest. The mTOR inhibitor temsirolimus is active in refractory MCL, with a 38% ...

Richter transformation describes the development of an aggressive lymphoma in patients with chronic lymphocytic leukaemia, ...

The company also has other products in its portfolio, including Umbralisib, an oral inhibitor for certain lymphomas ... a newly FDA-approved anti-CD20 monoclonal antibody, targets specific ...